|
This event was part of a postmarket study being conducted in (b)(6).A peripheral atherectomy procedure commenced to treat an in-stent reocclusion (isr) in the patient's left superficial femoral artery.Initially, on (b)(6) 2020, the isr was successfully treated with a spectranetics turbo elite laser atherectomy catheter and non-coated balloon catheter.However, on (b)(6) 2021, isr was again confirmed with no treatment recommended at this time.Then, on (b)(6) 2021, it was confirmed that the patient¿s health did not improve.The physician thought there was no relation between the isr and the turbo elite and the procedure.Approximately two weeks later on (b)(6) 2021, the lesion was treated with a spectranetics turbo elite laser atherectomy catheter and a jade 5.0mm balloon.An ivus catheter was in use during the procedure.Four days later on (b)(6) 2021, acute limb ischemia due to arterial thrombus was confirmed.Finally on (b)(6) 2021, percutaneous transluminal angioplasty was performed with use of plain old balloon angioplasty (poba).The procedure was completed successfully and the patient survived the procedure.This report captures the turbo elite device in use on (b)(6) 2021 that may have caused or contributed to the acute limb ischemia due to arterial thrombus, requiring intervention.There was no alleged malfunction of the turbo elite device in use during the procedure.
|